| Name | Title | Contact Details |
|---|
Bionix Medical Technologies has provided medical professionals with innovative medical devices since 1984. Bionix is proud to offer cerumen removal, wound care, feeding tube care, infant feeding, bolus control and nasal visualization products.
Newhouse Specialty Co Inc is a Santa Ana, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
The Argen Corporation is the world`s largest manufacturer of precious dental gold alloys, leader in zirconia manufacturing, and leading innovator of digital dentistry solutions and scrap refining services. With more than 50 years serving the dental industry, Argen now distributes to more than 100 countries with subsidiaries in Canada, China, Germany and the United Kingdom. Argen enables dental labs of all sizes to integrate digital into every aspect of their workflow by offering a wide range of digitally-produced products and services. Argen is proud to be a family-owned American company that manufactures the highest quality products in the US and is dedicated to treating customers like family.
Impel NeuroPharma is a Seattle-based company developing intranasal drug treatments for central nervous system (CNS) disorders. Impel has developed a novel drug delivery platform, the POD technology, that administers drug to the deep nasal cavity to improve the brain distribution of many drugs. Impel`s proprietary (POD) device technology enables entirely new categories of drugs, including biologics, to be delivered to the central nervous system using a cost-effective, disposable, non-invasive intranasal drug delivery device.
Median Technologies provides innovative imaging solutions and services to advance healthcare for everyone. As The Imaging Phenomics Company®, Median provides insights into novel therapies and treatment strategies. Our unique solutions, MediScan® for lesion management in patient care, Lesion Management Solution (LMS) for lesion detection, measurement and reporting in clinical trials, and our imaging phenotyping system iBiopsy®, together with our global team of experts, are advancing the development of new drugs and diagnostic tools to monitor disease and assess response to therapy. Median Technologies supports biopharmaceutical sponsors and healthcare professionals around the world in bringing new and targeted treatments to patients in need with an eye on reducing overall costs. This is how we are helping to create a healthier world. Founded in 2002, based in Sophia-Antipolis, France, with a US subsidiary in Boston, Median has received the label “Innovative company” by the BPI and is listed on Euronext Paris` Alternext market (ISIN: FR0011049824, ticker: ALMDT). The company is eligible for the PEA-PME SME equity savings plan setup and has received the label Pass French Tech Promotion 2016-2017.